Adaptation of the quality by design concept in early pharmaceutical development of an intranasal nanosized formulation
Keywords: حداکثر غلظت پلاسما; API; active pharmaceutical ingredient; Cmax; maximum plasma concentration; CQA; critical quality attribute; CPP; critical process parameter; EMA; European Medicines Agency; FDA; Food and Drug Administration; HA; sodium hyaluronate; ICH; International Conf